Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe close: Shares up after surprise rise in US payroll numbers

(Sharecast News) - European shares closed higher on Friday after a higher-than-expected rise in US non-farm payroll numbers last month boosted hopes that downward pressure on wages would help quell inflation and the need for more rate rises. The pan-regional Stoxx 600 index closed 0.74% higher at 472.26 with all major bourses higher.

The US economy added more jobs than expected in November, according to data released on Friday by the Bureau of Labor Statistics.

Non-farm payrolls rose by 199,000 following an unrevised 150,000 jump in October. Analysts were expecting a 180,000 increase.

Meanwhile, the unemployment rate ticked down to 3.7% in November from 3.9% the month before, versus expectations for it to remain unchanged.

Average hourly earnings rose 0.4% for the month and 4% on the year. The monthly jump was ahead of expectations of 0.3%, but the yearly rate was in line.

"The unemployment rate is trending upwards because rebounding immigration - it fell sharply during the pandemic - is driving rapid expansion of the labor force, more than offsetting the solid employment numbers. This is deeply unusual; cyclical increases in the unemployment rate usually are driven by weakening payrolls," said Ian Shepherdson, chief economist at Pantheon Macroeconomics.

"Either way, increasing slack in the labor market ought to push wage growth down further, consistent with the quits rate returning to its pre-Covid level. Ultimately, that's what matters for the Fed, because wage growth is the key driver of core services inflation ex-housing, which finally is breaking to the downside but is still too high."

In other economic news, the final estimate of Germany's consumer price index (CPI) confirmed that inflation fell to its lowest in 29 months in November.

In line with the provisional estimates released last week, CPI rose by 3.2% year-on-year last month, down from 3.8% in October, after prices fell by 0.4% during the month, according to Germany's federal statistics office, Destatis.

This was the fifth consecutive month of falling annual inflation, with falling energy prices accounting for a large part of the slowdown, while price pressures on food have also eased.

Energy prices were down 4.5% year-on-year, after a 3.2% annual decline the month before, which mainly reflect elevated prices in 2022 on the back of Russia's invasion of Ukraine. Food inflation meanwhile eased to 5.5% from 6.1%.

The core reading, which excludes the more volatile food and energy costs, stood at +3.8% in November, falling below the 4% mark for the first time since August 2022. Core inflation stood at 4.2% in October.

In equity news, Anglo American slumped by 19% after unveiling plans to cut expenditure by another $500m next year amid a 4% cut in production.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

FTSE 100 movers: JD Sports rallies; GSK hit by US Zantac ruling
(Sharecast News) - London's FTSE 100 was flat at 8,276.38 in afternoon trade on Monday.
US open: Stocks mixed as oil prices fall
(Sharecast News) - Wall Street trading got off to a mixed start on Monday after a big day for the blue-chip Dow Jones in the previous session.
Europe midday: Shares hold gains with eyes on ECB rate decision
(Sharecast News) - European markets were up as investors look ahead to the European Central Bank's interest rate decision on Thursday, widely expected to be a 25 basis point cut.
London midday: Stocks stay up but GSK tumbles on Zantac court ruling
(Sharecast News) - London stocks were still in the black by midday on Monday ahead of an expected rate cut by the European Central Bank this week, but GSK tumbled on the back of the latest US court ruling on its heartburn drug Zantac.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.